Clozapine is known to be an effective antipsychotic for schizophrenia. Cardiovascular complications associated with initiation of clozapine include tachycardia, postural hypotension, and myocarditis. Factors associated with development of cardiovascular adverse events are not clearly known, and dose titration has been described to be one among the associated risk factors. We report a case of a 45-year-old man with treatment resistant schizophrenia who developed supraventricular tachycardia during initiation of clozapine and discuss the role of verapamil in its successful management.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649798 | PMC |
| http://dx.doi.org/10.4103/0253-7176.162925 | DOI Listing |
Publication Analysis
Top Keywords
supraventricular tachycardia
8
initiation clozapine
8
clozapine-induced supraventricular
4
tachycardia treatment
4
treatment verapamil
4
verapamil clozapine
4
clozapine effective
4
effective antipsychotic
4
antipsychotic schizophrenia
4
schizophrenia cardiovascular
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!